Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Modern Economy

ISSN Print: 2152-7245
ISSN Online: 2152-7261
www.scirp.org/journal/me
E-mail: me@scirp.org

Google-based Impact Factor: 0.74
Citations h5-index & Ranking

Journals Menu

"Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria"
written by Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Georgi Momekov, Guenka Petrova,
published by Modern Economy, Vol.5 No.5, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Orphan medicinal products' access to the Bulgarian pharmaceutical market–challenges and obstacles
	Ecosystem Health and Sustainability, 2018

[2]	Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II
	Modern Economy, 2014

[3]	Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines-Part II
	Modern Economy, 2014

[4]	СЪЩНоСт И ИзПоЛзвАНЕ НА ИкоНоМИЧЕСкИ АНАЛИзИ ПРИ ПРовЕЖДАНЕ НА НАУЧНоИзСЛЕДовАтЕЛСкА РАзРАботкА
	Тзуни

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Modern Economy

Modern Economy

Journals Menu

Home

About SCIRP

Service

Policies

[1]	Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles Expert Opinion on Orphan Drugs, 2017 DOI:10.1080/21678707.2018.1421063